Kearny Venture Associates Iii, Llc
Venture capitalLate Stage
Also known as KVP CAPITAL ADVISORS, LP
Investment thesis
Kearny Venture Partners invests exclusively in emerging healthcare products, believing the opportunity for entrepreneurs to create innovative medical solutions is greater than ever. The firm sees persistent unmet needs in healthcare as large market opportunities for safe and effective products. As the molecular basis of disease becomes better understood, new avenues for intervention emerge and novel therapies can displace incumbent products. The firm aims to partner with and help transform exceptional companies advancing medicine.
Source: firm website, verified Sep 1, 2026.
Frequently asked questions
- What stage does Kearny Venture Associates Iii, Llc invest at?
- Kearny Venture Associates Iii, Llc invests at the Late Stage stage.
- What sectors does Kearny Venture Associates Iii, Llc focus on?
- Kearny Venture Associates Iii, Llc focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.